rs34612342
badMag 9.0This is a variant in the MUTYH gene that changes a tyrosine to an cysteine.
Key Literature Trait Associations
MUTYH-Associated Polyposis and Colorectal Cancer
The MUTYH Y179C variant (c.536A>G, p.Tyr179Cys) is one of the two most common pathogenic MUTYH variants in Northern Europeans. MUTYH is a base excision repair enzyme that corrects oxidative DNA damage. Homozygous carriers or compound heterozygotes (one Y179C plus one G396D) have up to 28-fold elevated colorectal cancer risk. Monoallelic carriers have a modest ~34% increase that remains controversial. All biallelic carriers should receive intensive surveillance starting at age 18–20.
Extracolonic cancer risk in MUTYH-associated polyposis
Biallelic MUTYH mutation carriers, including those with Y179C, face substantially elevated risks for extracolonic malignancies beyond colorectal cancer. A study of 276 MAP patients found standardized incidence ratios of 129 for duodenal cancer, 7.2 for bladder cancer, and 5.7 for ovarian cancer compared to the general population. Overall extraintestinal malignancy risk was nearly doubled (SIR ~1.9). These extracolonic risks apply to confirmed MAP (biallelic) carriers and inform surveillance guidelines beyond colonoscopy.
▶ClinVar annotation
Familial adenomatous polyposis 2; Endometrial carcinoma; not provided; Hereditary cancer-predisposing syndrome; not specified; Carcinoma of colon; Gastric cancer; Familial adenomatous polyposis 2;Gastric cancer; MUTYH-related disorder; Inherited polyposis and early onset colorectal cancer - germline testing; Dysembryoplastic neuroepithelial tumor; Medulloblastoma; Colorectal cancer; Pilocytic astrocytoma
View on ClinVar →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…